BioGaia starts its own distribution in Canada
Starting in 2023, BioGaia will be selling probiotics under its own management in Canada. Following the acquisition of Nutraceutics in...
Read moreStarting in 2023, BioGaia will be selling probiotics under its own management in Canada. Following the acquisition of Nutraceutics in...
Read moreWe are proud to announce that our probiotic for bone health, Osfortis, is the winner of the 2022 NutraIngredients Awards...
Read moreAt BioGaia’s Annual General Meeting held earlier today, on 6 May 2022, it was resolved on a share split...
Read moreThe Annual General Meeting of BioGaia AB (publ) on 6 May 2022 voted, among other things, to approve the following...
Read moreFIRST QUARTER 2022 Net sales amounted to SEK 283.9 million (202.0), an increase of SEK 81.9 million,...
Read moreWe are proud to announce that our probiotic for bone health, Osfortis, is the winner of the 2022 NutraIngredients Awards...
Read moreBioGaia AB (publ) will hold its Annual General Meeting on Friday, 6 May 2022. The meeting will be held through...
Read moreToday, BioGaia AB (publ) publishes its Annual Report, Remuneration Report and Sustainability Report for the financial year 2021. In line...
Read more